MintNeuro Raises $5 Million to Boost Neural Device Technology
MintNeuro, a London-based company specializing in developing semiconductor platforms for neural devices, has successfully raised $5 million in an undisclosed funding round. The round was led by Odyssey Ventures, with participation from investors such as 33East, JSK Investments, Alumni Ventures, Empirical Ventures, and Jumpspace Ventures.
Strategic Plans Post-Funding
MintNeuro, co-founded by CEO Dorian Haci and CTO Timothy Constandinou, is focused on transitioning from technology validation to commercial scaling. The company's unique semiconductor platform is already being integrated into neurotech devices, including implants. This funding will be instrumental in scaling the production of these specialized chips, which are purpose-built for neural devices.
"We are thrilled to have the support of such experienced investors," said Dorian Haci, CEO of MintNeuro. "This funding will allow us to enhance our manufacturing capabilities and broaden our market reach."
Investor Involvement
Odyssey Ventures led the funding round, marking its continued interest in healthtech innovations. Alongside Odyssey, other notable investors such as 33East, JSK Investments, and Alumni Ventures have shown their commitment to supporting MintNeuro's mission.
Use of Funds
The newly acquired capital will primarily be used to scale up the production of MintNeuro's semiconductor platform. This includes expanding their manufacturing capabilities and integrating their technology into a wider range of neural devices. The company aims to accelerate the commercial deployment of its products, enhancing the functionality and accessibility of neurotech solutions.
MintNeuro's advancements in neural device technology could significantly impact the healthcare industry, offering new possibilities for medical implants and other neurotech applications.